Nestle Chief Executive Mark Schneider does not rule out larger acquisitions in health-science operations to prop up sales, according to Germany`s Manager Magazin.
"I am not ruling this out," Schneider said when asked whether plans to raise sales of the health-science division to 10 billion Swiss Francs $10.41 billion) from 2 billion required bigger purchases. "But we are acting prudently."
The company is on track to meet its 2-to-4 percent sales growth target and wants to grow in a medium single-digit range from 2020 in organic terms, Schneider said in an interview published on Thursday.
On calls by activist investor Daniel Loeb to sell a stake in L`Oreal, the CEO said: "Nestle has performed exceptionally well with its engagement in L`Oreal for more than 40 years. I have nothing to add to this."
Separately, Schneider said the company has no plans to spin off slower-growing businesses outside its four defined growth areas.
($1 = 0.9607 Swiss francs)
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
05:39 PM IST